Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 6/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17138168 | 0.94 | KCNA3 (0.46) | ALDH1A1L3MBTL1KDM4ETDP1MEN1 | |
| SCHEMBL17138208 | 0.92 | PRSS1 (0.46) | ALDH1A1L3MBTL1KDM4ETDP1MEN1 | |
| SCHEMBL13349919 | 0.91 | TSHR (0.50) | ALDH1A1L3MBTL1MAPK1CYP1A2CYP2D6 | |
| SCHEMBL146017 | 0.91 | MAPK1 (0.54) | ALDH1A1L3MBTL1MAPK1CYP1A2CYP2D6 | |
| SCHEMBL19051155 | 0.89 | ALDH1A1 (0.44) | ALDH1A1L3MBTL1MAPK1CYP1A2CYP2D6 | |
| SCHEMBL22367610 | 0.89 | ALDH1A1 (0.44) | ALDH1A1L3MBTL1MAPK1CYP1A2CYP2D6 | |
| SCHEMBL31267597 | 0.87 | DRD2 (0.54) | ALDH1A1L3MBTL1MAPK1CYP2D6KDM4E | |
| SCHEMBL21310696 | 0.87 | HPGD (0.58) | L3MBTL1CYP1A2CYP2D6CYP2C19KDM4E | |
| SCHEMBL30375456 | 0.87 | TSHR (0.58) | ALDH1A1L3MBTL1PRSS1TSHR | |
| SCHEMBL30594499 | 0.87 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1KDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | ALDH1A1 133/4885L3MBTL1 2433/4885MAPK1 1198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.